SODIUM FLUORIDE F 18 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Fluoride F 18, and when can generic versions of Sodium Fluoride F 18 launch?
Sodium Fluoride F 18 is a drug marketed by Nih Nci Dctd and is included in one NDA.
The generic ingredient in SODIUM FLUORIDE F 18 is sodium fluoride f-18. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Fluoride F 18
A generic version of SODIUM FLUORIDE F 18 was approved as sodium fluoride f-18 by MCPRF on June 28th, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SODIUM FLUORIDE F 18?
- What are the global sales for SODIUM FLUORIDE F 18?
- What is Average Wholesale Price for SODIUM FLUORIDE F 18?
Summary for SODIUM FLUORIDE F 18
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 145 |
| Patent Applications: | 601 |
| DailyMed Link: | SODIUM FLUORIDE F 18 at DailyMed |
Recent Clinical Trials for SODIUM FLUORIDE F 18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Plymouth | EARLY_PHASE1 |
| Anabio R&D | NA |
| Hanoi Medical University | NA |
US Patents and Regulatory Information for SODIUM FLUORIDE F 18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nih Nci Dctd | SODIUM FLUORIDE F 18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 022494-001 | Jan 26, 2011 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
